Related Experiment Video

Updated: May 7, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

14.2K

Cardiac rehabilitation and outcome in stable outpatients with recent myocardial infarction

Roser Coll-Fernández1, Ramon Coll2, Teresa Pascual3

  • 1Department of Physical Medicine and Rehabilitation, Parc Taulí Sabadell, Hospital Universitari, Sabadell, Barcelona, Spain.

Archives of Physical Medicine and Rehabilitation
|October 15, 2013
PubMed

Insights

Cardiac rehabilitation significantly reduces mortality rates in patients following a recent myocardial infarction (MI). This structured program also shows a trend towards lowering subsequent ischemic events, improving patient outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Rehabilitation Medicine

Background:

  • Recent myocardial infarction (MI) poses a significant risk for mortality and subsequent ischemic events.
  • Cardiac rehabilitation is a structured program designed to improve cardiovascular health and recovery post-MI.

Purpose of the Study:

  • To compare mortality and subsequent ischemic event rates in patients with recent MI based on participation in cardiac rehabilitation versus no rehabilitation.
  • To determine the independent association of cardiac rehabilitation with patient outcomes after MI.

Main Methods:

  • A longitudinal observational study involving 1043 patients with recent acute MI.
  • Data collected from an ongoing registry of outpatients, with 521 participants (50%) engaging in cardiac rehabilitation.
  • Subsequent ischemic events (MI, ischemic stroke, limb amputation) and mortality rates were tracked over an 18-month follow-up period.

Main Results:

  • Patients in cardiac rehabilitation experienced significantly lower mortality rates (0.16 vs 5.57 deaths per 100 patient-years) and a trend towards fewer subsequent ischemic events (1.65 vs 4.54 events per 100 patient-years).
  • Multivariate analysis confirmed cardiac rehabilitation was independently associated with a significantly lower risk of death (HR=0.08, P=.016).
  • A nonsignificant reduction in subsequent ischemic events was observed in the cardiac rehabilitation group (HR=0.65).

Conclusions:

  • Cardiac rehabilitation is independently associated with a significant reduction in mortality for patients recovering from a recent MI.
  • While not statistically significant in this study, cardiac rehabilitation demonstrated a trend towards decreasing subsequent ischemic events.
Abstract

Keywords:
CIFRENAMIRisk Factors and Arterial Diseaseconfidence intervalmyocardial infarction

More Related Videos

Myocardial Infarction and Functional Outcome Assessment in Pigs12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

31.4K
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.0K

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
528
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
452
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
502
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802